Michel Mittelbronn Selected Research

viscum album peptide (Iscador)

1/2019	Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice.
1/2018	Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice.
2/2017	Viscumins functionally modulate cell motility-associated gene expression.
1/2012	Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Mittelbronn Research Topics

Disease

74	Neoplasms (Cancer) 02/2022 - 06/2005
54	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 06/2005
51	Glioma (Gliomas) 10/2021 - 05/2005
15	Hypoxia (Hypoxemia) 10/2020 - 01/2007
15	Brain Neoplasms (Brain Tumor) 10/2019 - 04/2005
15	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 04/2005
10	Neoplasm Metastasis (Metastasis) 10/2019 - 01/2011
7	Inflammation (Inflammations) 01/2022 - 06/2008
6	Stroke (Strokes) 03/2017 - 12/2008
6	Myocardial Ischemia (Ischemic Heart Diseases) 08/2015 - 03/2007
6	Ischemia 03/2013 - 03/2007
5	Parkinson Disease (Parkinson's Disease) 11/2022 - 02/2008
5	Melanoma (Melanoma, Malignant) 12/2016 - 01/2011
5	Oligodendroglioma 01/2016 - 11/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2005
4	Neuroinflammatory Diseases 01/2022 - 09/2013
4	Neurilemmoma (Schwannoma) 01/2020 - 09/2014
4	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 03/2017 - 08/2007
4	Primitive Neuroectodermal Tumors (PNET) 01/2016 - 05/2011
4	Infarction (Infarctions) 08/2015 - 03/2007
4	Medulloblastoma 11/2014 - 05/2011
3	Dementia (Dementias) 01/2022 - 02/2008
3	Testicular Neoplasms (Testicular Cancer) 01/2021 - 03/2016
3	Necrosis 11/2017 - 06/2012
3	Neuroblastoma 01/2017 - 11/2014
3	Carcinogenesis 07/2016 - 01/2011
3	Reperfusion Injury 03/2013 - 10/2007
3	Gliosis 01/2013 - 07/2008
2	Ataxia (Dyssynergia) 01/2021 - 02/2010
2	Carcinoma (Carcinomatosis) 10/2020 - 01/2013
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2020
2	Brain Edema (Cerebral Edema) 01/2020 - 05/2016
2	Ganglion Cysts (Ganglion) 01/2020 - 01/2004
2	Edema (Dropsy) 01/2020 - 03/2017
2	Breast Neoplasms (Breast Cancer) 10/2019 - 01/2013
2	Disease Progression 01/2019 - 09/2013

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2005
14	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2013
11	Messenger RNA (mRNA)IBA 01/2019 - 06/2005
10	EnzymesIBA 01/2017 - 08/2008
9	CytokinesIBA 01/2022 - 08/2007
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2013
9	Small Interfering RNA (siRNA)IBA 03/2019 - 06/2005
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 10/2008
8	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2009
7	Adenosine (Adenocard)FDA LinkGeneric 01/2016 - 03/2007
6	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2007
6	AntibodiesIBA 01/2021 - 01/2004
6	LigandsIBA 05/2019 - 09/2006
6	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 05/2011
5	Phosphotransferases (Kinase)IBA 01/2020 - 12/2010
5	Biological ProductsIBA 01/2020 - 08/2009
5	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 01/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2012
5	Lactic Acid (Lactate)FDA LinkGeneric 09/2017 - 07/2005
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2021 - 11/2011
4	viscum album peptide (Iscador)IBA 01/2019 - 01/2012
4	Glial Fibrillary Acidic ProteinIBA 09/2018 - 05/2012
4	Transforming Growth Factor beta (TGF-beta)IBA 08/2009 - 09/2006
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
3	alpha-SynucleinIBA 01/2022 - 02/2008
3	Lactate Dehydrogenase 5IBA 01/2021 - 10/2015
3	Alkylating AgentsIBA 12/2020 - 02/2008
3	Pharmaceutical PreparationsIBA 12/2020 - 05/2016
3	Monoclonal AntibodiesIBA 10/2020 - 01/2008
3	Viscum ribosome inactivating proteinIBA 01/2019 - 02/2017
3	TOR Serine-Threonine KinasesIBA 01/2019 - 01/2015
3	Carboxypeptidase H (Carboxypeptidase E)IBA 09/2017 - 07/2012
3	Matrix Metalloproteinases (MMPs)IBA 08/2017 - 01/2012
3	LectinsIBA 02/2017 - 04/2007
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017 - 08/2010
3	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 03/2013
3	AntigensIBA 11/2014 - 01/2004
3	Metalloproteases (Metalloproteinases)IBA 02/2013 - 09/2006
3	Oxygen (Dioxygen)IBA 07/2012 - 03/2007
3	5'-Nucleotidase (5' Nucleotidase)IBA 08/2008 - 03/2007
3	Aquaporins (Water Channels)IBA 06/2007 - 04/2005
2	InterleukinsIBA 01/2022 - 11/2015
2	SynucleinsIBA 01/2022 - 01/2022
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 12/2013
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2016
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021 - 01/2013
2	ParaffinIBA 01/2021 - 07/2008
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 04/2009
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 10/2017
2	Beclin-1IBA 01/2020 - 04/2016
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 01/2004
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 01/2018
2	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2019 - 07/2015
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 10/2013
2	Cisplatin (Platino)FDA LinkGeneric 06/2018 - 01/2011
2	gossypol acetic acidIBA 01/2018 - 01/2017
2	Extracellular Matrix ProteinsIBA 01/2018 - 05/2016
2	IntegrinsIBA 01/2018 - 01/2013
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 03/2015

Therapy/Procedure

37	Therapeutics 10/2020 - 03/2007
7	Drug Therapy (Chemotherapy) 01/2020 - 02/2008
7	Radiotherapy 01/2019 - 10/2007
4	Chemoradiotherapy 01/2016 - 04/2010
2	Transplantation 01/2019 - 06/2012